mulberroside B
CAS No. 75872-12-7
mulberroside B( —— )
Catalog No. M19082 CAS No. 75872-12-7
Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 284 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namemulberroside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
DescriptionAntitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75872-12-7
-
Formula Weight356.28
-
Molecular FormulaC15H16O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](OC2=C(O)C(O3)=C(C=C2O)C=CC3=O)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Maohuoside A
Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
-
JNJ-49095397
JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively.
-
UK 383367
UK-383367 is a procollagen C-proteinase inhibitor with IC50 of 44 nM, has excellent selectivity over MMPs.
Cart
sales@molnova.com